It is the strategy of Tianda Pharmaceuticals to pursue research and development on Chinese, chemical and biotech medicines by its R&D; team and cooperative efforts. By adopting this strategy, the Company keeps enriching its product portfolios with patented innovative medicines. The Company is proactive in pursuing cooperation with world renowned scientists, medical research institutions and academic organizations in order to globalize its R&D; network. Products under R&D;/manufacturing include cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory system drugs, anti-infective drugs, anti-diabetic drugs and anti-neoplastics drugs, detoxification drugs and other products. The Company is also preparing to invest in R&D; for vaccines and blood products to satisfy the vast demand for these products.